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ABBREVIATIONS 
 
 
 
         µl     microliter 
     µg    microgram 
    ATP               adenosine tri phosphate 
     bp    base pairs 
CTAB   cetyl trimethyl ammonium bromide 
    DNA   deoxy ribonucleic acid 
    DEPC    diethyl pyro carbonate 
    DU    duodenal ulcer 
    dNTP   deoxy nucleotide triphosphate 
    dATP   deoxy adenosine triphosphate 
    dTTP   deoxy thymidine triphosphate 
    dCTP   deoxy cytosine triphosphate 
    dGTP   deoxy guanosine triphosphate 
    EDTA   ethylene diamine tetra acetic acid 
    Et Br   ethidium bromide 
FP    forward primer  
    g      gravity    
    GU    gastric ulcer 
    GC    gastric carcinoma 
    IAA    iso amyl alcohol 
    IPA    iso propyl alcohol 
    Kb    kilobase 
    L    liter 
    M    molar 
    MALT   mucosa associated lymphoid tissue 
    mM    millimolar    
    NaCl   sodium chloride 
   NUD    Non Ulcer Dyspepsia  
    PBS    phosphate buffer saline 
 PUD              peptic ulcer disease 
 RP    reverse primers 
    rpm    rotations per minute 
    rRNA   ribosomal ribonucleic acid 
    RUT    rapid urease test 
    SDS    sodium dodecyl sulphate 
    TE    tris EDTA 
    TBE    tris boric acid EDTA 
    TAE   tris acetate EDTA 
    Tris Hcl   tris hydrochloric acid  
    U    unit 
    UBT    Urea breath test 
    V    volts 
GENES 
babB    blood group antigen –binding adhesion gene 
cagA-glr    cytotoxin associated gene A glutamate 
racemase 
Cag PAI   cytotoxin associated gene Pathogenicity 
Island 
Fla A&G                                flagellin genes 
Ice    induced by contact with epithelium gene  
Oip    outer inflammatory protein gene 
Ure A                                     ureas gene A 
Ure B                                     ureas gene B 
Ure C                                     ureas gene C ( glmM  )(phosphoglucosamine 
mutation  
                                                gene) 
Ure D                                     ureas gene D 
Ure E                                     ureas gene E 
Ure F                                     ureas gene F 
Ure G                                     ureas gene G 
Ure H                                     ureas gene H 
Ure I                                       ureas gene I 
Vac A     Vacuolating cytotoxin A gene 
RAPD    Random amplified polymorphic DNA 
Pic A&B   permitting induction of cytokines genes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                         Introduction        
Helicobacter pylori is a poly-flagellated, spiral, gram negative, micro-aerophilic,  
bacterium1, with 4-6 sheathed flagella that is involved in the pathogenesis of peptic ulcer 
diseases and is the main etiologic agent of duodenal ulcer and chronic atrophic gastritis. 
More than hundred Helicobacter species have now been identified, the majority being 
gastric organisms. H. pylori presence is not a disease in itself but a condition that affects 
the relative risk of developing various clinical disorders of the upper gastrointestinal 
tract. 
 Colonization with H. pylori always leads to infiltration of the gastric mucosa in 
both antrum and corpus with neutrophilic and mononuclear cells. This chronic active 
gastritis is the primary condition related to H. pylori colonization. Very little is known 
about the acute phase of infection and mostly come from reports of patients who ingested 
H. pylori or underwent procedures with contaminated gastric endoscopy apparatus.2  
 It has been found that, a close correlation exists between the level of acid 
secretion and the distribution of gastritis. This interaction is critical in the determination 
of outcomes of H. pylori infection. Approximately 95% of duodenal ulcers and 85% of 
gastric ulcers occur in the presence of H. pylori infection3.  The gastric mucosa does not 
normally contain lymphoid tissue, but MALT nearly always appears in response to 
colonization with H. pylori. In rare cases, a monoclonal population of B cells may arise 
from this tissue and slowly proliferate to form a MALT lymphoma.  
H. pylori is also related with coronary heart disease, dermatological disorders 
such as rosacea and idiopathic urticaria, autoimmune thyroid disease and 
thrombocytopenic purpura, iron deficiency anemia, Raynaud’s phenomenon, 
scleroderma, migraine, and Guillain-Barre´ syndrome. The mechanism by which it is 
related is by chronic low-grade activation of the coagulation cascade, accelerating 
atherosclerosis, antigenic mimicry between H. pylori and host epitopes leading to 
autoimmune disorders4.  
Attempts to show saliva as an appropriate specimen for diagnosing H.pylori have 
not shown consistent result. This may be due to low detection rates of H. pylori in the 
salivary secretion and low detection power of the method used. The reason could be that 
environment present in the mouth affects the survival of these organisms due to increased 
oxygen tension prevalent in some areas. Another reason could be the high contamination 
load with other organisms of the micro flora which suppresses the growth of H. pylori. 
The present study was designed to detect the presence of Helicobacter pylori 
in saliva of symptomatic and subjects selected randomly from our dental institution 
by using polymerase chain reaction technique. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                     
 
 
 
 
 
 
 
 
                                       
                Aims and Objectives    
 
 
 
 
Aims and objectives 
 
AIM                 - To identify the presence of H.pylori in saliva of patients with and 
        without gastritis by Polymerase Chain Reaction method. (PCR) 
OBJECTIVE     - To evaluate the presence of H.pylori in saliva of. 
                              1. Patients with symptoms of gastritis 
    2. All were asymptomatic at the time of study (four had previous history of     
        gastritis treated) 
HYPOTHESIS – Oral cavity is a reservoir of H.pylori and its presence correlates with  
     clinical gastritis                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           Materials and Methods 
 
Materials and Methods 
Materials 
A total of 20 patients presenting with various symptoms including epigastric pain, 
burning sensation in the stomach and attending an endoscopy clinic Sundaravadanam 
nursing home and Selvarangam nursing home, Chennai were enrolled for the study.  In 
group 2, all were asymptomatic at the time of study (4 had previous history of gastritis 
treated (n=10). A detailed case history was taken. The study was approved by the IRB 
and patient consent obtained for all cases. 
Endoscopy Biopsy and Saliva Specimens: 
• The gastro intestinal endoscopy antral biopsy and saliva 
specimens were collected from 20 symptomatic patients with  
gastroduodenal disorders. 
• PCR materials (Synergy chemicals) & Oligonucleotide Primers 
      were obtained from Bangalore Genei Ltd, Bangalore, India. 
• The general chemicals of analytical grade are from Owaisi 
      medical college and hospital, Hyderabad. 
Methods 
Isolation of Helicobacter pylori 
Collection and Transport of Specimens: 
Biopsy: A total of 2 biopsies were collected from patients using fiber optic video 
gastroendoscope with precautions under sterile conditions by a gastroenterologist. 
The forceps and endoscopes were decontaminated with 2% glutaraldehyde for 30 
min. to prevent cross infection among patients. 
Saliva: The saliva specimens were taken from all the 30 patients in sterile 
containers for molecular diagnostic tests before endoscopy in digestion buffer. 
Flow chart displaying stratification of study subjects. 
 
Sample size
n = 30
Gastritis
n = 20
Non-gastritis
n = 10
Positive 
n = 4
Negative 
n = 6
Positive 
n = 10
Negative
n = 10
Biopsy Clinical Cases
Positive 
n = 11
Positive 
n = 3
Negative 
n = 7
Negative
n = 9
PCR
 
COLLECTION OF UNSTIMULATED SALIVA: 
The patient was asked to sit in the chair with head tilted in front and instructed not to 
speak / swallow or do any head movements during the procedure. At the beginning, 
the patient was asked to swallow any saliva if present in the mouth. After this the 
patient was instructed to spit in the sterile graduated container every minute for 10 
minutes. All salivary samples were collected between 7am to 8 am 
Digestion buffer 
 100mM NaCl 
 10mM Tris-HCl 
 25mM EDTA 
 1%SDS 
Isolation of Genomic DNA from Saliva Specimens by kit method 
 
1. Collect fresh saliva in collection tube. 
↓ 
2. Add 300µl saliva to a 1.5ml microcentrifuge tube. 
↓ 
3. Add 3 times the sample vol of Real Biotech Corporation (RBC) lysis buffer and 
mix by inversion method. 
↓ 
4. Incubate the tube for 5 min at room temperature. 
↓ 
5. Centrifuge at 300 rpm for 2 min and discard supernatent. 
↓ 
6. Add 100 µl RBC lysis buffer to resuspend the cell pellet. 
CELL LYSIS: 
7. Add 200µl GB buffer (commercially available and used for cell lyses) to tube and 
mix by  vortexing. ↓ 
8. Incubate the mixture at room temperature for 10 min until the sample lysate is 
clear.During incubation invert the tube every 3 min. 
↓ 
9. At this time, preheat required elution buffer (commercially available) (200µl per 
sample) in a 70° C   waterbath (for DNA elution) 
DNA BINDING: 
10. Add 200µl of ethanol (96-100%) to sample lysate and mix immediately by vortexing 
for 10 seconds. 
↓ 
11. Place a GD (a tube with a sieve) column in 2ml collecting tube. 
↓ 
12. Apply the total mixture (including any ppt) from previous step to GD column. 
↓ 
13. Close cap and centrifuge at full speed 13000rpm. 
 
WASH: 
14. Add 400 µl of W1 buffer (wash buffer, commercially availabe) into GD column. 
↓ 
15. Centrifuge full speed 13000 rpm 30 sec. 
↓ 
16. Discard the flow-through and place the GD column in 2ml collecting tube. 
↓ 
17. Add 600 µl of wash buffer in GD column. 
↓ 
18. Centrifuge at full speed 13000 rpm 30 sec. 
↓ 
19. Discard the flow-through and place the GD column in 2ml collecting tube. 
↓ 
20. Centrifuge at full speed 13,000 rpm for 3 min to dry column matrix. 
DNA elution 
21   Transfer dried GD column into clean 1.5 ml micro-centrifuge tube. 
↓ 
22. Add 100 µl of preheated elution buffer into the centre of column matrix. 
↓ 
23. Stand at room temperature for 3-5 min until elution buffer absorbed by matrix. 
↓ 
24. Centrifuge 13000 rpm for 30 sec to elute purified DNA. 
↓ 
25. Store at - 4 ° C. 
Polymerase Chain Reaction 
PCR was done using the genomic DNA isolated from the saliva and the biopsies of the 
patients as the template to detect the presence of the 16S rRNA gene in H. pylori. 
Molecular diagnosis of Helicobacter pylori: 
16S rRNA gene 
The presence of H. pylori was diagnosed by 16S rRNA PCR amplification of the DNA. 
The Polymerase Chain Reaction (PCR) was carried out using 16S rRNA primers and the 
DNA isolated from the saliva specimens of the subjects. The amplified product gives a 
534 bp band upon agarose gel electrophoresis using a 2 % gel at 120v. 
16S rRNA primers: 
Forward primer 5’ – TAAGAGATCAGCCTATGTCC – 3’ 
Reverse primer 5’ – TCCCACGCTTTAAGCGCAAT- 3’ 
PCR Mixture 
The PCR mixtures used were commercially available 
PCR Conditions 
The reaction conditions for the16S rRNA gene amplification with both the primers were 
optimized and are as follows: 40 cycles with denaturation at 94°C for 30 sec; annealing 
temperature at 56°C for 30 sec and synthesis at 72°C for 1min. 
The reaction cycles are as follows: 
 
950 C for 5 min (Initial denaturation step) 
940 C for 30 sec 
560 C for 30 sec 40 cycles 
720 C for 1 min 
720 C for 5 min (Final extension step) 
Positive (ATCC 26695 strain) and negative controls are kept for the validation of the 
PCR performed. The negative control consists of the reaction mixture without the DNA 
template. The positive control contains the H. pylori DNA as the template. 
Electrophoresis Conditions: 
PCR products were visualized after electrophoresis at 120v on 2% agarose gel containing 
15µl Ethidium bromide under UV light. The PCR product size was 534 bp 
 
 
 
Statistical analysis 
Descriptive analysis for all the variables were done and the accuracy of the PCR 
technique was estimated using sensitivity, specificity, positive predictive value (ppv), and 
negative predictive value(npv) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
 
 
 
 
 
 
 
 
            Review of Literature 
Review of literature 
 Jang L, Cherng P, Rong et al in March 19995 studied H-pylori in gastric biopsy 
specimen by 5 different PCR methods to determine which method is the most appropriate 
one to use, and compared the sensitivities and specificities. They found that for  ureC ( 
phosphoglucosamine (glmM) )gene PCR is the most appropriate of the five different PCR 
methods examined for detection of H. pylori organisms. 
 Farhana K, Abid H, Irshad A et al in November 20046 compared the genomes of 10 
H. pylori strains from Ladakh, North India. Molecular analysis was done to identify 
rearrangements within and outside the cag pathogenicity (cag PAI) and DNA sequence 
divergence in candidate genes. Analysis of virulence genes such as the cag PAI as a 
whole, cagA, vacA, iceA, oipA, babB, and the plasticity cluster revealed that H. pylori 
strains from Ladakh are genetically different and may be less virulent than the isolates 
from East Asian countries. Phylogenetic analysis based on the cagA-glr, enterobacterial 
repetitive intergenic consensus patterns, repetitive extragenic palindromic signatures, the 
glmM gene mutations, and several genomic markers representing fluorescent amplified 
fragment length polymorphisms revealed that Ladakh strains share features of the Indo-
European and also the East Asian gene pools.  
 Song Q, Lange T, Spahr A et al in April 19997 studied the prevalence and distribution 
of H. pylori in oral cavity by nested PCR .They took saliva and plaque samples from 42 
patients who were undergoing endoscopy and found that, H. pylori DNA was identified 
in dental plaque of 41 patients (97%) and in 23 saliva samples (55 %). They concluded 
that H. pylori were present in oral cavity of 97 % of tested samples and so they may 
belong to normal oral microflora. 
  Francesco F, Antonia R, Antonio G, et al in March 20028 studied to determine whether 
anti-CagA antibodies cross-react with antigens of normal and atherosclerotic arteries. To 
see this, they took 8 umbilical cord sections, 14 atherosclerotic artery sections, and 10 
gastrointestinal tract sections and did immunohistochistry using polyclonal anti-CagA 
antibodies. They found that Anti-CagA antibodies cross-reacted with antigens of both 
normal and atherosclerotic blood vessels. So they concluded that the binding of anti-
CagA antibodies to those antigens in injured arteries could have influenced the 
progression of atherosclerosis in CagA-positive H pylori-infected patients 
 Vaishnavi B, Vikram K, Nilakantan A et al in 20049 conducted a study to determine 
the prevalence of H pylori in patients with portal hypertensive gastropathy (PHG) and 
also to determine if it contributes to the severity of the disease. They selected 37 patients 
who presented with portal hypertensive gastropathy and looked for H. pylori by urease 
test and histology. They found that 16 of 37 were positive for H pylori, 27 patients had 
endoscopic evidence of mild PHG, 9 had moderate and 1 patient had evidence of severe 
PHG. The H. pylori status was 52%, 22%, and 0% in patients with mild, moderate, and 
severe gastropathy respectively indicating an inverse relationship of severity of PHG with 
H. pylori colonization. From this they concluded that PHG does not provide a favorable 
environment for the colonization of H. pylori  
  Dowsett S, Kowolik M et al in 200310 reviewed the evidence for a definitive role of the 
oral cavity in transmission of H. pylori and the role of the oral cavity as a reservoir for 
gastric H. pylori infection by culture and PCR. They concluded that there is increasing 
evidence for a role of the oral cavity in transmission of H. pylori . If the oral cavity is a 
reservoir for gastric infection, in even a minority of individuals, this can be sufficient to 
warn a preventive approach that encompasses consideration of the oral reservoir 
  Dowsett S, Archila V, Segreto A et al in April 199911 studied the possible sources of 
H. pylori infection in an isolated, rural population in Guatemala. A total of 242 people in 
family units were included in the study. By serological test immunoglobulin G antibodies 
to H. pylori were detected. Overall, 58% of subjects were seropositive, with a positive 
relationship between mother and child (P = 0.02) and a positive correlation between the 
serostatuses of siblings. There was no association between serostatus and gastric 
symptoms. Oral H. pylori was detected from periodontal pockets of different depths and 
the dorsum of the tongue by nested PCR. 87 % of people had minimum one oral site 
positive for H. pylori, with majority of people having multiple positive sites. There was 
no association between periodontal pocket depth and the detection of H. pylori. Nested 
PCR was also used to detect H. pylori from beneath the nail of the index finger of each 
person’s dominant hand. Overall, 58% of people had a positive fingernail result. With a 
positive relationship between fingernail and tongue positivity with this they concluded 
that oral carriage of H. pylori may play a role in the transmission of infection and that the 
hand may play a major role in transmission. 
 Donald F, Chuanfu L, Nikhil P et al in July 199312 studied whether H. pylori can be 
grown in saliva samples of patients, who were positive for gastric biopsy samples by 
soluble-protein electrophoresis, restriction endonuclease DNA analysis, and southern blot 
hybridization. They founded that viable H. pylori could be cultured from saliva samples. 
 
 Qiang H,  Jian P, Michael O et al   in July 200213studied on the development of a real-
time quantitative (Q) PCR-based assay to measure ureC gene copy number to detect H. 
pylori, based on the fact that there is only one copy of the ureC gene per bacterium. Upon 
optimization of Light Cycler Q-PCR conditions, they obtained a standard curve with a 
linear range (correlation coefficient = 1) across six logs of DNA concentration. They 
were able to accurately quantify as few as 1,000 bacteria in their assay. Analysis of 
variance on 15 randomly selected clinical samples showed good reproducibility of this 
assay.  
 Reilly T, Poxon V, Sanders D et al in 199714 compared a new rapid whole blood test 
(Helisal rapid blood, Cortecs), two serum enzyme linked immunosorbent assays 
(ELISAs; Helico-G, Shield and Helisal serum, Cortecs), and a salivary assay (Helisal 
saliva, Cortecs), with slide biopsy urease, 13C-urea breath test, and histology. With 303 
consecutive dyspeptic patients attending for gastroscopy, underwent 2 antral biopsies for 
histology, and one for rapid slide biopsy urease test for assessment of H.pylori status. 
Blood and saliva were also collected. Of the 303 patients, 100 underwent a 13C-urea 
breath test. They found that, out of 300 patients (median age 63,range 28–89) eligible for 
analysis, 137(46%) were gold standard positives, of which Helisal rapid blood identified 
116, Helico-G 129, Helisal serum 130, and Helisal saliva 120; 137 (46%) were gold 
standard negatives of which the number falsely identified as positive was 30 by Helisal 
rapid blood, 45 by Helico-G, 41 by Helisal serum, and 41 by Helisal saliva. Sensitivities 
and specificities were: for the whole blood test 85% and 78% respectively; for Helico-G 
94% and 67%, for Helisal serum 95% and 70%, and for Helisal saliva 84% and 70%.  
 
  Pascalis R, Del P, Nardone G et al in Feb 199915 conducted a study on salivary 
immunoglobulin G (IgG) immune response to Helicobacter pylori in 70 people by 
enzyme-linked immunosorbent assay (ELISA). Patients with a positive H. pylori culture 
showed higher antibody titers than subjects with no detectable H. pylori: the overall 
sensitivity and specificity of the test were 84% and 90% respectively. With this they 
concluded that the detection of salivary anti-H. pylori IgG antibodies may be used as an 
alternative to serum IgG detection when blood samples are not available in screening of 
patients with dyspepsia. 
 Julie P, Haim S, Thomas H et al in 199916 done a study to determine the route of 
transmission of H. pylori and also to see if H. pylori could be recovered from feaces, 
vomitus, and saliva of asymptomatic, infected adults by culture and Immunomagnetic 
separation PCR (IMS PCR). They took 16 asymptomatic H. pylori infected and 10 
uninfected individuals. They found that all vomitus samples grew H. pylori. Saliva  
before and after emesis grew low quantities of H. pylori in 3 (18.8%) and 9 (56.3%) 
cases. All stool samples were negative by culture but in 5 infected subjects IMS PCR 
detected H. pylori 16s rRNA. They concluded that healthy H. pylori could be cultured 
from saliva vomitus and stools of infected persons. 
 Alejandra B, Marianella P, Mari A et al in 200217 studied to determine the presence of 
H. pylori DNA in the gastric antrum and dental plaque of a Venezuelan population by 
PCR and the relationship between this infection and the oral hygiene index. In this study 
they took 32 patients, attending for routine gastroscopy, and 20 asymptomatic subjects. 
Patients’ supragingival plaque was tested by a PCR for a specific internal urease gene. 
Gastric antrum biopsies were taken for histological examination and PCR. H. pylori was 
detected in antral samples from 24 (75%) of 32 patients, H. pylori was also detected in 
dental plaque samples of 12 (37.5%) of the 32 patients. In 7 (58%) of these 12 patients, 
H. pylori was identified in the gastric biopsy. 7 patients with chronic gastritis carried H. 
pylori in dental plaque and antral samples. Of these patients, 4 also had dysplasia and one 
had metaplasia. 3 subjects in the control group were positive by PCR. They said that 
there is no correlation between H. pylori infection, dental hygiene, dental caries, 
periodontal disease or use of dentures. They concluded that the oral cavity may be a 
reservoir for H. pylori infection and oral secretions may be a means of transmission of 
this organism. 
 Bruce A, Deanna K, Geraldine M et al in 200218 studied the relationship between H. 
pylori infection and abnormal periodontal conditions. In this study they used 4504 
participants aged 20 to 59 years who underwent a periodontal examination and tested 
positive for H. pylori antibodies by ELISA. And found that Periodontal pockets with a 
depth of 5 mm or more were associated with increased odds of H. pylori seropositivity 
(odds ratio [OR]=1.47; 95% confidence interval [CI]=1.12, 1.94) after adjustment for 
sociodemographic factors. With this they concluded that poor periodontal health, with 
advanced periodontal pockets, may be associated with H. pylori infection in adults, 
independent of socio-economic status. 
 Fariborz M, Mehdi A, Amir H et al in 200519 studied on H. pylori in brush biopsy 
samples of oral aphthous ulcers by the polymerase chain reaction (PCR) method. Patients 
who were diagnosed as RAS were referred to the laboratory in Rasht city. Oral aphthous 
specimens were collected by toothbrush from the patients. Enzyme-linked 
immunosorbant assay (ELISA) was also done in all patients to determine IgG antibody. 
They found that of the 50 patients with ages between 18 to 60 years (mean ±SD: 
32.38±11.30), 26 patients (52%) had positive ELISA but H. pylori DNA was found in 
only one patient (2%). With this they concluded that, H. pylori DNA could not be found 
in the aphthous ulcers of these patients, even in patients with positive anti-H.pylori 
antibody (IgG), and these bacteria are not involved in recurrent oral aphthous ulcers. 
  MacKay W, Williams C, McMillan et al in 200320 did a study on to develop a 
noninvasive method to isolate H. pylori DNA. In this study a total of 30 children were 
included and were tested for gastric H. pylori colonization by using the 13C-urea breath 
test (UBT) and fecal samples, which were tested for H. pylori by using the HpSA fecal 
antigen test. They found that among 15 UBT-positive and 15 UBT-negative children, the 
positive and negative predictive values for the assay were 80 and 100% and concluded 
that feacal DNA purification followed by H. pylori PCR analysis is an effective method 
for H. pylori DNA isolation from the feaces of children.  
 Goosen C, Theron J, Ntsala M et al in 200221 studied to develop a heminested PCR 
assay based on the amplification of a specific internal region of the Phosphoglucosamine 
mutase gene (glmM) of H. pylori and evaluated the heminested PCR assay for the 
detection of H. pylori in saliva and dental plaque by comparison with an established PCR 
assay. In this they took oral specimens like dental plaque and sulcular fluid, with sterile 
toothpicks and filter paper, respectively, from 58 randomly selected, clinically healthy 
volunteers attending the Gastroenterology Unit at Pretoria Academic Hospital, Pretoria, 
South Africa. All oral specimens were cultured and DNA was isolated and a set of 
primers specific for the phosphoglucosamine mutase gene (glmM) of H. pylori produced 
a 765-bp fragment that was used as template for the heminested primer pair delineating a 
496-bp fragment. They found that the heminested PCR assay was specific for detection of 
H. pylori, with no false-positive results, and that H. pylori had a low prevalence 
(approximately 3%) in specimens obtained from the oral cavity. 
 Anak I, Siriporn C, Sukanya L et al in 200322 studied the association of H. pylori and 
RAU (Recurrent aphthous ulceration) using, nested polymerase chain reaction (PCR), in 
22 patients with RAU with ages ranging from 12-36 years. Samples were taken from the 
lesions on the dorsum of the tongue of each patient and also, from the dorsum of the 
tongue of 15 normal individuals with ages of 13-40 years who were used as controls. The 
results showed that one sample from a lesion (4.5%) and one sample from the tongue 
(4.5%) of two different patients with RAU were positive for H. pylori. In the control 
group, 3 samples (20%) were positive for H. pylori. With this they concluded that H. 
pylori do not play a role in the pathogenesis of RAU and the dorsum of the tongue may 
be a reservoir of H. pylori. 
 Patrizia S, Vittorio R, Roberto F et al in199823 studied  
1) The delivery of VacA to cells,  
2) The localization and fate of internalized toxin, and  
3) The persistence of toxin inside the cell, 
in cultured gastric epithelial cells. In this they used human gastric epithelial cells in 
culture and broth culture filtrate from a VacA-producing H. pylori strain The techniques 
used were neutral red dye uptake, ultrastructural immunocytochemistry, quantitative 
immunofluorescence, and immunoblotting. They found that 
1)  VacA is delivered to cells in both free and membrane-bound form (i.e., as vesicles 
formed by the bacterial outer membrane), 
 2) Localizes inside the endosomal-lysosomal compartment, in both free and membrane-
bound form,  
3) Persists within the cell for at least 72 h, without loss of vacuolating power and 
generally does not degrade into fragments smaller than, 90 kDa. 
 Maher T, Sharon M, Jane G et al in 199924 studied on the endoscopic biopsy 
pathology of Helicobacter pylori gastritis and compared bacterial detection by 
immunohistochemistry using a specific antibody with the Genta stain, to compare the 
relative costs of the 2 techniques. For this they took 100 cases of gastritis identified as 
positive for H pylori by Genta stain and 100 cases considered negative by the same 
technique and stained using an anti-H pylori–specific polyclonal antibody. They found 
out that Chronic active gastritis with lymphoid follicles was significantly associated with 
H pylori infection (P < 0.0001). The immunohistochemical method had sensitivity of 
97% and a specificity of 98% compared with the Genta stain. Reagent costs were similar 
for both methods, but immunohistochemistry using an autoimmunostainer required less 
technical time and hence was less expensive than the Genta stain. With this they 
concluded that Immunohistochemistry using a specific antibody is an accurate and cost-
effective method for H.pylori detection in gastric biopsies. 
 Britta B, Ragnar B, Bernhard J et al in 199825 studied to develop a PCR-based 
method to detect macrolide resistance and the virulence gene cagA in H. pylori within 24 
h, to improve the lengthy process of culture-based procedures. Total DNA was prepared 
directly from stomach biopsy specimens. The procedure proved to be rapid and reliable 
and could be utilized for diagnostic purposes. For this biopsy samples were collected 
from 69 patients (39 females and 30 males; mean age, 57 years) and concluded that this is 
rapid and reliable and could be utilized for diagnostic purposes. 
  Allaker R, Young K, Hardie J M et al in 200226 studied to find out the possible route 
of transmission in children. In this study they took 100 children attending for upper 
gastrointestinal endoscopy were tested for the presence of H. pylori and this organism 
was detected in antral gastric biopsies by the rapid urease test (13 patients), culture (13 
patients), histology (15 patients) and PCR (20 patients). Gastric juice was positive for H. 
pylori in 3 patients by culture and 11 patients by PCR. The dental plaque from 68% of 
gastric biopsy-positive patients and 24% of gastric biopsy-negative patients was positive 
for H. pylori by PCR. H. pylorus in dental plaque was same as that of in the stomach. H. 
pylori was detected by PCR in the faeces of 25% of gastric biopsy-positive children 
sampled. With this they concluded that oral-to-oral transmission may be a possible mode 
of spread of H. pylori in children. 
 Patrizia D, Stefano B, Anna Rita et al in 199927 studied the   rate of intra familial 
transmission of Helicobacter pylori infection in the general population and the role of a 
family's social background. In this they took 3289 residents, accounting for 416 families. 
It was found out that the overall prevalence of H pylori infection was 58%. Children 
belonging to families with both parents infected had a significantly higher prevalence of 
H pylori infection (44%) than children from families with only one (30%) or no parents 
(21%) infected (P < 0.001). Family social status was independently related to infection in 
children, with those from  farming families showing an increased risk of infection 
compared with children of high class families (odds ratio 2.02, 95% confidence interval 
1.16 to 3.49). With this they concluded that H pylori infection clusters within families 
belonging to the same population. Social status may also be a risk factor. 
 Mohamed N E, Magdy E M et al in 200528 the presence of H.pylori and, if detected, its 
potential prevalence in causing recurrent aphthous ulcers confined to mucosa associated 
lymphoid tissues of the pharynx. They did prospective, controlled clinical trial. In this 
study they took 146 patients with recurrent multiple aphthous ulcers of the oral cavity and 
pharynx and 20 normal control subjects. Patients were divided into group 1 (n=58), in 
which the ulcers were strictly limited to the lymphoid tissues, and group 2 (n=88), in 
which the ulcers were randomly distributed in the oral cavity and pharynx. H. pylori 
DNA was extracted from 3-mm-diameter tissue samples, and PCR amplifications were 
done for the 16S ribosomal RNA gene. They found, that in group one, 39 patients (67%) 
were positive for H pylori DNA, while in group two, 9 patients (10%) were positive (P < 
0.001). It was not detected in any of the 20 control samples. With this they concluded that 
there could be a possible causative role for H.pylori in recurrent aphthous ulcers with a 
characteristic distribution and affinity to mucosa-associated lymphoid tissues of the 
pharynx. 
Anna H, Rikka I, Vuokko L et al in 200429 studied the sensitivity of H.pylori to 
physiological concentrations of lactoperoxidase and its salivary substrate thiocyanate and 
different amounts of hydrogen peroxide (H2O2) in buffer and in human whole saliva and 
concluded that concentrations of lactoperoxidase and its salivary substrate thiocyanate, 
and different amounts of hydrogen peroxide do not seem to generate enough antibacterial 
property to effectively kill H.pylori 
 
 Czesnikiewicz M, Karczewska E, Bielanski W et al in 200430 studied the relationship 
of H.pylori in oral and gastric infections. They included 100 patients in the study. Gastric 
infection was determined by C-urea breath test UBT. In addition oral saliva and plaque 
were cultured. Of which H.pylori was present in 51 % of stomach, 54 % saliva and 48.3 
% of samples from gingival pockets. The difference was not statistically significant. They 
concluded that oral cavity contamination with H.pylori occurs at similar degree to that in 
the stomach and there was no correlation between the occurrence of H.pylori in stomach 
and oral cavity. 
    Loster B W, Majewski S W, M Nikiewicz G et al in 200631 compared the bacterial 
culture from the oral mucosa to those from the gastric mucosa, by PCR. In this study 40 
men (25-70 yrs) were induced and they found that the oral bacteria and bacteria from 
stomach are completely different, suggesting that H. pylori may be present only 
transiently in oral cavity and does not play major role in gastric H. pylori infection. Thus, 
oral cavity does not serve as bacterial reservoir to infect gastric mucosa. 
 Bee L N, Seng H Q, Marion A et al in 200332 studied the role of coccoid form in H. 
pylori infection by comparing the seroprevalences of spiral and coccoid forms in children 
with epigastric pain. In this study 489 children (mean age, 8.5 years) with epigastric pain 
participated. 599 schoolchildren of comparable ages, with no history of dyspepsia were 
used as controls. The seroprevalence of antigens prepared from both morphological forms 
were tested by ELISA, and they found out that 65 (13.3%) and 273 (55.8%) of 489 
symptomatic children were seropositive for antigens of the H. pylori spiral and coccoid 
forms and, 7.0% of the control group had increased levels of immunoglobulin G 
antibodies against the spiral form, while 26.5% were positive for antibodies against the 
coccoid form. With this they concluded that the seroprevalence of antigens of the H. 
pylori spiral and coccoid forms in children with epigastric pain was two fold higher than 
that in the control subjects. 
 Asish K , Dangeruta K, Jin Y  et al in 200033 studied the differences between strains of 
East Asia and the West.  For this they took adult ethnic Bengali patients of both sexes, 
age 21 to 65 Years. Endoscopy biopsies and gastric juice samples were taken. Two 
biopsies were taken for culture, 1 from the gastric antrum and 1 from the corpus, and 
were stored at 270°C in 0.5 ml of brucella broth (Difco) with 15% glycerol until culture. 
2ml of gastric juice was also collected during endoscopy in some cases and stored frozen 
at 270°C until use. They employed culture and PCR techniques. It was found that 55 of 
the patients had peptic ulcer disease, and 23 had gastritis only. With this they postulated 
that- 
• PCR tests indicated that 80 to 90% of Calcutta strains carried the cag 
pathogenicity island (PAI) and potentially toxigenic vacAs1 alleles of the 
vacuolating cytotoxin gene (vacA), independent of disease status.  
• This was higher than in the West (where cag PAI1 vacAs1 genotypes are 
disease associated) but lower than in East Asia. 
• In Calcutta the iceA2 gene was weakly disease associated, where as in the 
west the alternative but unrelated iceA1 gene at the same locus is weakly 
disease associated.  
• DNA sequence motifs of vacAm1 (middle region) alleles formed a cluster 
that was distinct from those of East Asia and the West, whereas the cagA 
sequences of Calcutta and Western strains were closely related. 
• An internal deletion found in 20% of Calcutta iceA1 genes was not seen in 
any of ~ 200 strains studied from other geographic regions and thus 
seemed to be unique to this H.pylori population.  
• 2 mobile DNAs that were rare in East Asian strains were also common in 
Calcutta.  
With the above findings they concluded that, H. pylori gene pools differ regionally. 
 Abdussalam A, Guilherme B , Edilberto N et al in 200134 studied the frequency of 
iceA alleles and cagA status in H.pylori strains. For this study they took 142 patients (62 
children and 80 adults; 66 female; mean age, 30.0 years; age range, 3 to 78 years) with 
gastritis, duodenal ulcer, or gastric adenocarcinoma. iceA was identified in bacterium 
samples obtained from all patients.iceA2 allele was detected in 118 (90.1%) and was 
associated with ulcer (P = 0.02) and with carcinoma (P = 0.001). iceA2 amplicons of 
229, 334, or 549 bp were detected and  were more frequent in patients older than 7 years 
(P = 0.001). This gene was also more frequent in strains obtained from males (P = 0.02).  
cagA was more common in strains obtained from carcinoma (P =0.0008) and ulcer 
patients (P < 0.006). cagA-positive strains were more frequent in children older than 7 
years (P < 0.003). 
With the above findings they concluded that iceA should not be used as a reliable marker 
for predicting the clinical outcome of H. pylori infection. 
Marinko M, Zarko B, Mirjana N et al in 200535 studied the role of proton pump 
inhibitors in patients of unsuccessful eradication of H pylori. For this they took 335 
patients with gastritis (142 males and 193 females, mean age 51.3 years, between 18 and 
83 years). All patients underwent upper gastrointestinal endoscopy with histopathologic 
examination and they found that there is no significant difference in resolution of 
Intestinal metaplasia by using different PPI between the groups of eradicated and 
noneradicated patients (P<0.4821 and P<0.4388, respectively).  
 Leisa M, Anthony P, Andrew C et al in 200436 studied on the role of TLRs in the 
recognition of H. pylori, H. felis, and H. hepaticus. Here they used normal human 
monocytes and macrophages, transfected cell lines, and genetically deficient animals; 
they showed that TLR2 is an important cytokine signaling receptor for H. pylori, H. felis, 
and H. hepaticus. Further, they said that although the lipopolysaccharide (LPS) of H. 
pylori is recognized by TLR4, the major TLR for intact Helicobacter bacteria is TLR2 
and not TLR4. 
Tiwari S K, Khan A, Manoj G et al in 200737 studied on developing a multiplex PCR 
assay for diagnosing and specific identification of virulent H. pylori strains and their 
main virulence genes cagA, cagE, cagT, vacA and hrgA. For this study they used 
Genomic DNA from 82 gastric tissues. Multiplex PCR assay was able to detect all the 
five target genes in 81.7 % and deletions in one or more loci among 18.3%. Genotype 
cagT +ve ⁄  hrgA +ve ⁄  cagA +ve ⁄  cagE +ve ⁄  vacAs1 +ve was predominant in this study 
population(67.07%). hrgA, cagT, cagE and cagA genes were present in 100%,92.7%, 
85.4% and 81.7% respectively. The vacAs1 subtype had higher prevalence frequency in 
patients with overt gastrointestinal disease (78.57%) than with GERD (gastro-esophageal 
reflux disease) and NUD (nonulcerdyspepsia) (50%). With the above findings they 
concluded that multiplex PCR assay developed here was able to genotype H. pylori 
isolates based on the main virulence genes. 
Ahmed K S, Khan A, Ahmed I et al in 200638 studied the routes of transmission of 
H. pylori. For this study, they took saliva and biopsy samples of 400 people and did PCR. 
With this, they found out that the H. pylori in saliva and biopsy samples increased with 
age. It was found more commonly in the saliva and biopsy samples among males (64 % 
and 60 %, respectively) than females (53.3 % and 64 %). 71.6 % and 73.5 % of those 
who consumed municipal water acquired H. pylori compared to a lesser proportion (12.6 
% and 12.6 %) of those who consumed boiled or filtered water. They also found that 
subjects who have home-cooked food (57.1 % and 57.7 %) showed a lower prevalence of 
H. pylori in saliva and biopsy samples, compared to those (80 % and 88%) who 
frequently ate out. With the above findings they concluded that transmission of H. pylori 
also takes place through the consumption of food prepared under unhygienic conditions. 
Consumption of municipal tap water also has a high impact in the transmission of H. 
pylori. 
 Tiwari S K, Khan A, Ahmed K S et al in 200539 studied on standardizing a cost 
effective, non-invasive method for the rapid diagnosis of H. pylori in salivary secretion of 
infected patients with gastric disorders using 16S rRNA PCR analysis. For this study they 
took 100 patients (65 men and 35 women) with a mean age of 48.4 (range 21 to 73) 
years. The patients were classified at the time of endoscopy into two groups, those having 
gastric diseases (n=80), and those with no evidence of mucosal ulcer and gastritis (n=20) 
i.e. normal study. With this they found that 72 (90 %) of the symptomatic group and 10 
asymptomatic subjects were infected with H. pylori in the stomach by PCR amplification 
of biopsy DNA obtained from each subject. H. pylori DNA was identified in the saliva of 
70 (87.5 %) symptomatic patients and 12 (60%) asymptomatic control patients. With the 
above findings they concluded that increased number of organisms identified in saliva 
indicate that saliva of the infected person can serve as a reliable non-invasive alternative 
to detect the presence of H. pylori infection. 
Goodwin C, Armstrong A, Chilvers T et al in 198940 studied on identification of a 
bacterium. “Campylobacter pyloridis,” or “Campylobacter pylori” but is now named 
Helicobacter pylori in recognition of the fact that this organism is distinct from members 
of the genus Campylobacter. The genus Helicobacter belongs to the subdivision of the 
Proteobacteria, order Campylobacterales, family Helicobacteraceae. This family also 
includes the genera Wolinella, Flexispira, Sulfurimonas, Thiomicrospira, and Thiovulum. 
The genus Helicobacter consists of 20 recognized species, with many species waiting for 
recognition. Members of the genus Helicobacter are all microaerophilic organisms and in 
most cases are catalase and oxidase positive, and many but not all species are also ureases 
positive. Helicobacter species can be subdivided into two major classes,  
1. The gastric Helicobacter species and 
2. The Enterohepatic (nongastric) Helicobacter species. 
Kuipers J, Uyterlinde M, Pena A  et al in 199541 studied on patients with intact acid 
secretion, H. pylori in particular, colonize the gastric antrum, where few acid-secretory 
parietal cells are present. Patients, in whom acid secretion is reduced, have a more even 
distribution of bacteria in antrum and corpus, and bacteria in the corpus are in closer 
contact with the mucosa, leading to a corpus-predominant pangastritis.  
Eidt S, Stolte M and Fischer R et al in 199442 studied on MALT lymphoma patients are 
H.pylori positive, and found out that H. pylori-positive subjects have a significantly 
increased risk for the development of gastric MALT lymphoma. A major predictor for 
response appears to be the presence of a t(11;18) (q21;q21) translocation. 
                                                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                          Results 
 . The study population comprised of patients with symptoms of gastritis (group 1) 
(n=20) and the randomly selected group (group 2) (n=10) 
In the (group1) 20 cases of clinical gastritis, 10(50%) were positive for H. pylori 
by endoscopy biopsy under modified Giesma stain and 10 (50%) were negative for the 
stain.  
Of the 10 endoscopy biopsy positive for H. pylori, 8 cases were PCR positive for 
H.pylori in saliva and 2 were negative. Of the 10 endoscopy biopsy negative cases, 3 
were PCR positive for H. Pylori in saliva and the rest 7 were negative. 
In randomly selected (group2) 10 cases were taken of which 6 were not clinically 
symptomatic of gastritis and 4 were symptomatic for gastritis. Out of 6 gastritis negative, 
3 were PCR positive for H.pylori and out of 4 gastritis positive, 3 were PCR positive for 
H.pylori. 
In group 1 there were 14 males and 6 females. In group 2 there were 6 females 
and 4 males. The mean age of the patients in group 1 was 39.43 (SD = ±10.01   ) in males 
and 52.33 (SD = ±19.83) in females. In group 2, there were 4 males and 6 females. The 
mean age of the patients in group 2 was 27.75 (SD = ± 2.06) in males and 27.83(SD = 
±4.54) in females. 
The saliva sample from all the patients in group 1 and group 2 was collected as 
per the protocol as stated in methodology. By using PCR the samples were subjected for 
detection of H.pylori using specific primers which has been shown in gel documentation 
picture. 
  
The gel consisted of 18 wells. The counting was done from left side as DNA 
ladder was put in the second well. From left side in well numbers 3, 4, 5, 6, 7 , 14 , 15 , 
16,  samples number  4,6,10,12,13,14,16 were loaded. 
Figure 1 shows Gel image of 16S rRNA amplification of H. pylori DNA isolated 
from the gastritis patients. In lane 1 and lane 2,100 bp DNA ladder was added. Lanes 4, 
6, 7, 15, and 16 shows 16S rRNA amplification of H. pylori DNA isolated from saliva of 
patients. Lane 17 shows the amplification of positive control (ATCC 26695). Lane 18 is 
the negative control. 
Figure 2 shows Gel image of16S rRNA amplification of H. pylori DNA isolated 
from the gastritis patients. In Lane 2:  100 bp DNA ladder was added. In Lanes 3, 7, 8, 
10, 12 and 14 16S rRNA amplification of H. pylori DNA isolated from saliva of patients 
was seen. Lane 17 shows the amplification of positive control (ATCC 26695). Lane 18 is 
the negative control 
 Figure 3 shows Gel image shows 16S rRNA amplification of H. pylori DNA 
isolated from the normal controls. In the lane 2 100 bp DNA ladder was added. Lanes: 6, 
7, 8, 9, 10, 11 shows 16S rRNA amplification of H. pylori DNA isolated from saliva of 
normal controls. Lane 17 positive control (ATCC 26695). Lane 18 is negative control. 
Of all the H. pylori, positive samples, the mean age was 35.3 ± 11.8 years while 
the negative samples age was 41.5±16.3 years. Of the 17 PCR positive subjects, 7 were 
females and the rest 11 were males.  
There were bands corresponding to 534 bp size at the level above 500 bp ladder in 
correspondence with the level of band for positive control - ATCC which identified the 
presence of H. pylori. Histological examination by the modified Giemsa of the biopsy 
section showed the presence of H. pylori in 10 cases (50%) of the total 20 symptomatic 
subjects. Out of the 10 clinically asymptomatic subjects who were taken as controls, the 
rate of detection with PCR was 60% (6/10). This organism was also detected in saliva 
samples of 11 (55%) of the 20 patients who had active gastric disease proven by 
histology, whereas saliva samples from 6 (60%) subjects in the control group of 10 
were found to be positive by PCR.  
Sensitivity of PCR in detection of H. pylori in saliva sample of patients who had 
clinical symptoms of gastritis and diagnostic biopsy as positive was 80%. The specificity 
of PCR in detection of H. pylori in saliva sample of patients who had clinical symptoms 
of gastritis and diagnostic biopsy as positive was 70%. The positive predictive and 
negative predictive values of PCR in detection of H. pylori in saliva sample of patients 
who had clinical symptoms of gastritis and diagnostic biopsy as positive were 72.7% and 
77.7% respectively.   
We also estimated the sensitivity, specificity, positive predictive value and 
negative predictive value of PCR for H. pylori detection from salivary samples of both 
study groups. They were 58%, 50%, 82.35 % and 23% respectively.  
 
 
 
 
 
 
 
 Diagnostic test values for PCR 
 Sensitivity  Specificity Positive 
predictive  
value 
Negative 
predictive 
value 
Biopsy + 
gastritis 
80 % 70% 72.7 % 77.7 % 
clinical 
gastritis + 
PCR 
58 % 50 % 82.35 % 23% 
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Table 1    Distribution of Gender among the Study Group 
 
 
 
 
 
 
 
 
 
 
 
 
          
       
GROUP 1:   Patients with symptoms of gastritis 
            GROUP 2    Post graduate students who were randomly recruited in this study from  
          our dental institution   
  
Graph 1  
DISTRIBUTION OF GENDER AMONG THE SUDY GROUP
0
10
20
30
40
50
60
70
80
GROUP 1 GROUP 2
%
 O
F 
M
A
LE
S
 A
N
D 
FE
M
A
LE
S
MALE
FEMALE
 
 
 
 
 
 
 
 
                Male                     Female  
 %  % 
GROUP 1 
(n=20) 
14 70% 6 30% 
GROUP2 
(n=10) 
4 40% 6 60% 
 
Table2 Correlation of H.pylori PCR in saliva (G1) and subjects asymptomatic at the time 
of study (4 had previous history of gastritis treated) (G2) 
   
 
 
   
 
 
 
 
 
 
 
 
 
Graph 2 Correlation of H.pylori PCR in saliva (G1) and subjects asymptomatic at the time 
of study (4 had previous history of gastritis treated) (G2) 
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                                 Gastritis     
Positive Negative 
Positive  14 3 
Negative 10 3 
PCR 
Total  24 6 
 
 
Table 3    Relation between the results of gastric biopsy and PCR detection of H.pylori in     
                Saliva (G1) 
 
 
 
                                 Biopsy     
Positive Negative 
Positive  8 3 PCR 
Negative 2 7 
Total  10 10 
 
 
Graph 3 
 
RELATIONSHIP BETWEEN THE RESULTS OF GASTRIC 
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            Table 4 Distribution of group2 subjects based on gastritis symptoms and   
                         PCR reports 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Graph 4   Distribution of group2 subjects based on gastritis symptoms and PCR     
                             reports 
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 PCR Total 
  Positive Negative   
GASTRITIS Present 
3 1 4 
  Absent 
3 3 6 
Total 
6 4 10 
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Figure 1 
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 Fig 1 Gel image shows 16S rRNA amplification of H. pylori DNA isolated from the 
patients. Product size: 534 bp. 
  
Lane 1                            :  100bpmolecular weight marker 
Lanes 4, 6, 7, 15, and 16: 16S rRNA amplification of H. pylori DNA isolated 
                              from saliva of patients,  
Lane 17                           : positive control (ATCC 26695),  
Lane 18         : negative control 
 
 
 
 
Figure 1:Lane 4,6,7,15 and 16  corresponds to 16S rRNA amplification fo H.pylori DNA  
isolated from saliva samples of gastritis patients (group1) with sample number 1,2,5,7,8 
as in Annexure 1 
 
 
 
 
 
 
 
 
 
 
Figure 2  
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Figure 2 Gel image shows 16S rRNA amplification of H. pylori DNA isolated from the 
patients. Product size: 534 bp. 
  
Lane 2                                :  100bpmolecular weight marker 
Lanes 3, 7, 8, 10,12 and 14: 16S rRNA amplification of H. pylori DNA isolated 
                                  from saliva of patients,  
Lane 17                              : positive control (ATCC 26695),  
Lane 18            : negative control 
 
 
 
 
Figure 2:Lane 3,7,8 ,10, 12, and 14  corresponds to 16Sr RNA amplification fo H.pylori 
DNA  isolated from saliva samples of gastritis patients(group1) with sample number 
9,13,14,16,18,20 as in annexure 1 
 
 
 
 
 
Figure 3  
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Figure 3: Gel image shows 16S rRNA amplification of H. pylori DNA isolated from the  
group 2 Product size: 534 bp. 
  
Lane 2                                :  100bpmolecular weight marker 
Lanes: 6,7,8,9,10,11  are   : 16S rRNA amplification of H. pylori DNA isolated 
                                  from saliva of normal controls 
Lane 17                              : positive control (ATCC 26695),  
Lane 18            : negative control 
 
 
Figure 3:Lane 6,7,8,9,10,11  corresponds to 16S rRNA amplification fo H.pylori DNA  
isolated from saliva samples of group 2 with sample number 4,5,6,7,8,9 as in annexure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
                           Discussion 
 
 
 
 This study has shown that in 56.67 % (17 cases out of 30) of study population, H. 
pylori was diagnosed with the help of saliva samples which was comparable with the 
results obtained from biopsy /histopathological analysis of the gastric tissues of the 
infected subjects. Further, the presence of H. pylori was also diagnosed, using saliva, in 
asymptomatic subjects who were later found to have a history suggestive of gastritis at 
some point of time in the past 6 months.  
At present there are a number of diagnostic tests - both invasive and non-invasive 
tests available for the diagnosis of H. pylori infection. They have varying sensitivity and 
specificity along with specific limitation in clinical applications. Urease-based biopsy 
tests require invasive and traumatic endoscopy and are not reliable in cases where 
patients had used proton pump inhibitors priorly. Histological examination follows 
endoscopy with its accuracy dependent on the method used to collect/ transport 
specimen, stain selected and on the pathologist’s skill. Serology is relatively inexpensive 
but is not reliable in determining the presence of active infection, which is important for 
clinical interpretation, making diagnosis as well as determining prognosis. 
Our successful amplification and detection of H. pylori DNA directly from saliva 
samples in the majority of infected subjects indicates that this approach is non-invasive, 
feasible and reliable with a sensitivity of 82.35% and specificity of 23.08%. Gel images 
(fig1 and fig2 ) also  exhibited  bands at 1000 bp ladder, which could be due to primer 
dimer. This demonstrates that it has true potential in aiding the diagnosis/ estimating the 
prognosis of patients with active H. pylori infection. This indicates that H. pylori when 
isolated from gastric mucosa most probably also could have been observed in salivary 
secretion and when isolated from salivary secretion, is not indicative of the gastric 
colonization by H. Pylori. 
Earlier attempts made in the past to prove saliva as a better specimen for 
estimating H. pylori did not yield satisfactory data for which low detection rates of H. 
pylori in the salivary secretion, low detection power of the method used and lesser 
number of viable organism have been suggested39. There were attempts made to detect H. 
pylori by PCR from saliva and dental plaques that showed low rates of detection43. On the 
other hand, Weiss et al in comparative study of the sensitivity, specificity, and predictive 
value of PCR of formalin-fixed biopsies showed that the 16S rRNA gene of H. pylori, 
has a high accuracy in demonstrating the presence of H. pylori in gastric biopsy 
specimens. In our study, H. pylori DNA was identified by PCR in the saliva of 56.67% 
(17 cases out of 30) of patients, with 11 cases proven with gastric symptoms in group 1 (n 
= 20) and 3 subjects with history of gastric symptoms in group 2 (n = 10, 4 having history 
of gastritis). Among the 10 controls, we observed 60% positivity for H. pylori in the 
saliva and 4 of them confirmed that they had occasional symptoms of gastritis. These 
results indicate that the clinical symptoms of gastritis are not a reliable indicator of oral 
H. Pyroli status.  
 H. pylori DNA were not identified in the saliva of 10 of the study population who 
had clinical symptoms or proven gastritis as evident from biopsy and history. The reason 
for this failure to identify H. pylori DNA in the saliva of the 10 samples is unknown. 
However, H.pylori was also identified by PCR assay in saliva specimens from 3 control 
patients whose history did not give a clear picture of gastritis. The relationship between 
gastric symptoms and H. pylori DNA in saliva, however, is unclear. It could be possible 
that the oral cavity is the initial site of infection. H. pylori may persist in low numbers in 
the oral cavity of these subjects for a long time without colonizing the stomach or gastric 
lining. There are reports with supportive44 evidence for the presence of H. pylori in the 
oral cavity. These observations along with our findings suggest that the oral cavity could 
be a reservoir of H. pylori infection and oral secretion may be an important means of 
transmission of H. pylori.  
As the presence of H. Pylori in saliva is comparable to the presence in gastric 
mucosa in our study, it could be said that its presence in saliva is a reliable marker of 
gastric mucosal immunity status. However studies involving genotypic status of oral H. 
pylori and gastric H. pylori, if found similar, would prove that oral cavity as a gate way 
of this infection and saliva as a means of transmission. Such studies have been carried out 
and none of them could prove that both of them are of the same strain. In contrast45 that 
same strain was present in both sites, in an isolated study. 
The results of our study indicate that H. pylori DNA is demonstrated accurately 
using PCR (11 cases) in contrast to the existing standard biopsy (n= 10 cases). In 5 cases, 
the histopathology did not correlate with the PCR result. This ambiguity may be due to 
low detection power of the stains used, the pathologist skills and lesser number of viable 
organisms existing in tissue to be demonstrated histopathologically. 
The results of our study indicate that analysis of saliva for H. Pylori may 
potentially be useful sample and saliva could serve as an effective valuable, noninvasive 
specimen to diagnose/ monitor the prognosis in comparison to existing diagnostic 
modalities. 
 
 
 
 
 
 
 
 
 
 
              Summary and Conclusion  
 
 
 
 1. 30 subjects were enrolled for the study. 
2. 20 cases were symptomatic gastritis, of whom 10 had biopsy proven H.pylori 
infection. 
3.  In group 2, all were asymptomatic at the time of study (n =10) (four had previous 
history of gastritis treated). 
4. The mean age of male patients in group1 was 39.43 ± 10.01 and female patients 
was 52.33 ±.19.83. 
5. The mean age of male subjects enrolled in group 2 was 27.75 ± 2.06 and female 
patients was 27.83 ± 4.54 
6. When biopsy was taken as gold standard, PCR of saliva showed sensitivity of 
80%, specificity 70%, positive predictive value 72.2% and negative predictive 
value 77.7% respectively. 
7. When clinical gastritis was used as standard for comparison with PCR of saliva, 
the sensitivity was 58%, specificity was 50%, positive predictive value was 82.35 
% and negative predictive value was 23% respectively.  
In conclusion, the results of our study indicate that PCR analysis of saliva is useful for 
identification of H. Pylori. Saliva could serve as an effective, valuable, noninvasive 
specimen to diagnose / monitor the prognosis of H. Pylori infection in comparison to 
existing diagnostic modalities. However, the exact sensitivity and specificity of saliva 
based PCR to diagnose H. pylori needs to be demonstrated in further studies involving 
larger samples.  
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MASTER CHART OF PATIENTS 
 
S.No 
Sample 
number Age Gender Biopsy report Pcr report Special 
   male 
positive/ 
negative 
positive/ 
negative  
1 4 39 male negative negative  
2 6 36 female positive positive  
3 10 27 male negative negative  
4 12 72 female positive positive  
5 13 48 female negative positive 
difference in 
results of 
biopsy n pcr 
6 14 58 female positive negative 
difference in 
results of 
biopsy n pcr 
7 16 40 male positive positive  
8 18 32 male negative positive 
difference in 
results of 
biopsy n pcr 
9 20 25 female positive positive  
10 21 35 male positive negative 
difference in 
results of 
biopsy n pcr 
11 28 75 female negative negative  
12 32 58 male negative negative  
13 35 47 male positive positive  
14 38 28 male positive positive  
15 39 40 male negative negative  
16 42 27 male negative positive 
difference in 
results of 
biopsy n pcr 
17 45 47 male negative negative  
18 58 35 male positive positive  
19 67 57 male negative negative  
20 77 40 male positive positive  
  
MASTER CHART OF CONTROLS 
 
 
 
S.no Sample.no Age Gender Pcr gastritis 
   Male Positive  
1 1 30 female Negative absent 
2 2 24 female Negative absent 
3 3 25 female Negative absent 
4 4 25 female Positive absent 
5 5 36 female Positive absent 
6 6 28 Male Positive present 
7 7 30 Male Positive present 
8 8 27 female Positive present 
9 9 28 Male Positive absent 
10 10 25 Male Negative present 
